Laminin (925-933): Defined ECM Peptide for Cell Adhesion and Migration Assays

Executive Summary: Laminin (925-933) is a synthetic peptide derived from residues 925-933 of the laminin B1 chain and represents a key tool for extracellular matrix (ECM) research. It specifically binds laminin receptors, supports cell adhesion and chemotaxis, and can competitively inhibit full-length laminin's effects in vitro (APExBIO). This peptide demonstrates robust activity in cell attachment and migration assays at concentrations of 100–300 µg/mL. Laminin (925-933) is highly soluble in water, ethanol, and DMSO and is supplied as a solid for research use. These properties enable reproducible, high-fidelity studies of cell-ECM interactions, metastasis, and ECM signaling (Taylor et al., 2023).

Biological Rationale

Laminins are a family of large glycoproteins that are major non-collagenous components of basement membranes. The laminin B1 chain contains biologically active sequences, including residues 925–933 (Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg), which mediate cell adhesion, migration, and signaling processes (APExBIO). Laminin (925-933) is designed to mimic the native cell attachment site, providing a defined tool for dissecting ECM-driven cellular behaviors. Targeting these pathways is critical in understanding cancer metastasis, tissue regeneration, and neurobiological processes (see prior review—this article emphasizes solubility and inhibition benchmarks not covered there).

Mechanism of Action of Laminin (925-933)

Laminin (925-933) selectively binds to the laminin receptor, which is expressed on the surface of many cell types. This interaction initiates intracellular signaling cascades that regulate cell adhesion, differentiation, and migration. The peptide's sequence is homologous to a region of the laminin B1 chain known to mediate cell attachment and chemotaxis. Functionally, Laminin (925-933) can stimulate cell attachment and acts as a chemoattractant, particularly for B16F10 murine melanoma cells, achieving approximately 30% of the maximal chemotactic response compared to full-length laminin at optimal concentrations (APExBIO). Additionally, it competitively inhibits the chemotactic response to native laminin, serving as a tool for dissecting receptor-mediated cell migration (prior report; this article details competitive inhibition data).

Evidence & Benchmarks

• Laminin (925-933) stimulates attachment of HT-1080 and CHO cells to culture plates at 100–300 µg/mL, under standard tissue culture conditions (APExBIO, product documentation).
• Acts as a chemoattractant for B16F10 murine melanoma cells, eliciting ~30% of maximal chemotaxis compared to full-length laminin at equivalent concentrations (APExBIO, source).
• Competitively inhibits the chemotactic response to full-length laminin, confirming its receptor specificity (APExBIO, source).
• Molecular weight is 967.06 Da; solubility is ≥15.53 mg/mL (water), ≥17.77 mg/mL (ethanol), and ≥48.35 mg/mL (DMSO) at room temperature (APExBIO, source).
• Peptide is stored at -20°C; solutions recommended for short-term use only (APExBIO, source).
• In translational research, ECM peptides such as Laminin (925-933) facilitate modeling of metastasis and ECM-driven signaling in advanced systems (Taylor et al., 2023).

Applications, Limits & Misconceptions

Laminin (925-933) is widely used in cell adhesion and migration assays, particularly in oncology and neurobiology research. It enables reproducible assessment of ECM-driven cell behaviors and supports mechanistic studies of metastasis and cell signaling. The peptide's defined sequence and receptor specificity offer advantages over complex ECM mixtures, reducing variability in experimental outcomes (previous coverage; here we specify precise solubility and cell-type data).

Common Pitfalls or Misconceptions

• Not a Full-Length Laminin Substitute: Laminin (925-933) mimics a specific domain and cannot replicate all activities of the full-length laminin protein.
• Species and Cell-Type Specificity: Activity may vary depending on cell type and receptor expression; validation is necessary for new applications.
• Not for Diagnostic or Clinical Use: The product is intended exclusively for in vitro research; it is not suitable for therapeutic or diagnostic procedures.
• Short-Term Solution Stability: Peptide solutions are not stable for long-term use and should be freshly prepared for each experiment.
• Concentration-Dependent Effects: Effective concentrations are defined (100–300 µg/mL); deviation may result in suboptimal or nonspecific effects.

Workflow Integration & Parameters

Laminin (925-933) is shipped as a solid and should be stored at -20°C. For cell-based assays, dissolve the peptide in sterile water (≥15.53 mg/mL), ethanol (≥17.77 mg/mL), or DMSO (≥48.35 mg/mL). Use freshly prepared solutions to ensure activity. Typical working concentrations are 100–300 µg/mL for cell adhesion or migration assays. For chemotaxis experiments, apply the peptide to the lower chamber of a Boyden chamber system. The defined molecular weight (967.06 Da) allows for precise molar calculations and reproducible dosing (Laminin (925-933) from APExBIO).

Conclusion & Outlook

Laminin (925-933), as offered by APExBIO, provides a highly defined, receptor-specific ECM peptide for dissecting cell adhesion and migration mechanisms. Its competitive inhibition profile and robust solubility make it an ideal tool for cancer metastasis and basement membrane signaling research. The peptide's reproducibility and specificity enable advanced modeling of ECM-driven processes in both oncology and neuroscience. For detailed roles in translational neurodegeneration models, recent work (Taylor et al., 2023, preprint) highlights the rising importance of ECM peptides in ex vivo brain tissue studies. This article extends the scope of previous reports by providing updated quantitative benchmarks and workflow integration guidance for Laminin (925-933).